FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Apr. 17, 2019--
MEDNAX, Inc. (NYSE: MD), will host an investor conference call and
webcast on Thursday, May 2, 2019 at 10:00 a.m. ET, to discuss results
from operations for the three months ended March 31, 2019. A detailed
press release will be issued the morning of May 2, 2019 before the
securities markets open.
The investor conference call will be webcast and can be accessed at
MEDNAX’s website, www.mednax.com/investors.
ABOUT MEDNAX
MEDNAX, Inc. is a national health solutions partner comprised of the
nation's leading providers of physician services. Physicians and
advanced practitioners practicing as part of MEDNAX are reshaping the
delivery of care within their specialties and subspecialties, using
evidence-based tools, continuous quality initiatives, clinical research
and telemedicine to enhance patient outcomes and provide high-quality,
cost-effective care. The Company was founded in 1979, and today, through
its affiliated professional corporations, MEDNAX provides services
through a network of more than 4,200 physicians in all 50 states and
Puerto Rico. In addition to its national physician network, MEDNAX
provides services to healthcare facilities and physicians in over 40
states through two complementary businesses, consisting of a management
services company and a consulting services company. Additional
information is available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,”
“will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could
cause actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX’s
most recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s
current reports on Form 8-K,filed with the Securities and Exchange
Commission, and include the effects of economic conditions on MEDNAX’s
business; the effects of the Affordable Care Act and potential changes
thereto or a repeal thereof; MEDNAX’s relationships with
government-sponsored or funded healthcare programs, including Medicare
and Medicaid, and with managed care organizations and commercial health
insurance payors; MEDNAX’s ability to consummate the proposed
disposition of MedData; the effects of share repurchases; and the
effects of MEDNAX’s shared services and operational initiatives.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190417005155/en/
Source: MEDNAX, Inc.
Charles Lynch
Vice President, Strategy and Investor Relations
954-384-0175,
x 5692
charles_lynch@mednax.com